Its about biology
The Bottom Line Large new studies suggest that people with Type 2 diabetes who take semaglutide may be less likely to develop dementia but current evidence does not prove cause and effect
G3 (Bethesda) 8(3):845-857 Matsubayashi, Y., Louani, A., Dragu, A., Snchez-Snchez, B.J., Serna-Morales, E., Yolland, L., Gyoergy, A., L Vizcay, G., Fleck, R.A., Heddleston, J.M., Chew, T.L., Siekhaus D., Stramer B
Sadgrove NJ, Simmonds MSJ
#DiversifyRx #PharmacyBadass #IndependentPharmacy #CompoundingPharmacy #Peptides To view or add a comment, sign in Business News: Merck gets US FDA nod for first-in-its-class oral cholesterol drug - Reuters: * Merck gets US FDA nod for first-in-its-class oral cholesterol drug Reuters * The F.D.A